Table 1 SARS-CoV-2 injectable vaccines granted emergency use listing by WHO
From: Beyond COVID-19: the promise of next-generation coronavirus vaccines
No. | Vaccine name | Manufacturer/Developer | Vaccine type |
|---|---|---|---|
1 | AZD1222/ Vaxzevria | AstraZeneca/Oxford Jenner Institute, UK | Nonreplicating viral vector (ChAdOx1) |
2 | AD5-nCoV/ Convidecia | CanSino Biological/Beijing Institute of Biotechnology/Academy of Military Medical Sciences, China | Nonreplicating viral vector (Ad5) |
3 | Covishield | AstraZeneca/ Oxford Jenner Institute, UK | Nonreplicating viral vector (ChAdOx1) |
4 | Ad26.COV2.S | Johnson & Johnson/Janssen Pharmaceuticals, USA/Belgium | Non-replicating viral vector (Ad26) |
5 | mRNA-1273/ Spikevax | Moderna/NIAID, USA | mRNA |
6 | BNT162b2/ Comirnaty | BioNTech/Pfizer, Germany/USA | mRNA |
7 | Covaxin/BBV152 | Bharat Biotech/Indian Council Medical Research/National Institute of Virology, India | Inactivated SARS-CoV-2 |
8 | BBIBP-CorV/ Covilo | Sinopharm CNBG/Beijing Institute of Biological Products, China | Inactivated SARS-CoV-2 |
9 | CoronaVac | Sinovac Biotech, China | Inactivated SARS-CoV-2 |
10 | NVX-CoV2372/ Nuvaxovid | Novavax | Inactivated SARS-CoV-2 protein subunit |
11 | COVOVAX | Serum Institute of India | Inactivated SARS-CoV-2 protein subunit |
